The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations
Open accessAbstract
BACH1 is a nuclear protein that directly interacts with the highly conserved, C-terminal BRCT repeats of the tumor suppressor, BRCA1. Mutations within the BRCT repeats disrupt the interaction between BRCA1 and BACH1, lead to defects in DNA repair, and result in breast and ovarian cancer. BACH1 is necessary for efficient double-strand break repair in a manner that depends on its association with BRCA1. Moreover, some women with early-onset breast cancer and no abnormalities in either BRCA1 or BRCA2 carry germline BACH1 coding sequence changes, suggesting that abnormal BACH1 function contributes to tumor induction. Here, we show that BACH1 is both a DNA-dependent ATPase and a 5′-to-3′ DNA helicase. In two patients with early-onset breast cancer who carry distinct germline BACH1 coding sequence changes, the resulting proteins are defective in helicase activity, indicating that these sequence changes disrupt protein function. These results reinforce the notion that mutant BACH1 participates in breast cancer development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the P47A variant identified in 2001 [8] and shown to disrupt FANCJ enzyme function [56] was found in the controls of a subsequent study and considered to be unrelated to breast cancer [44].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [56]
In the citing paper
“As predicted, the ATPase and helicase functions were inactivated by a single missense mutation (K52R) in the ATP-binding pocket of the FANCJ helicase domain [56,61,62].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [56]
In the citing paper
“These studies revealed that wild-type FANCJ is a DNA-dependent ATPase, which unwinds DNA in a 5′ to 3′ direction [56].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [56]
In the citing paper
“Consistent with enzyme activity being essential for tumor suppression, the breast cancer-associated mutation in helicase block II (P47A) or an FA-associated mutation in the Fe–S domain (A349P) reduced FANCJ enzyme activity [42,56,63].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [56]
In the citing paper
“The P47A mutant had disrupted enzyme activity”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [56]
In the citing paper
“the M299I mutant had enhanced ATPase, helicase and translocase activity [56,61]”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [56]
Citations
Cites
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Sancar, A. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.000355 · Cited by 1,131
The BRCT Domain Is a Phospho-Protein Binding Domain
Yu, X., Chini, C. C. S., He, M., Mer, G., & Chen, J. (2003) · Science · doi:10.1126/science.1088753 · Cited by 862
A superfamily of conserved domains in DNA damage‐ responsive cell cycle checkpoint proteins
Bork, P., Hofmann, K., Bucher, P., Neuwald, A. F., Altschul, S. F., & Koonin, E. V. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034168 · Cited by 746
Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus
Cheng, M. Y., Bullock, C. M., Li, C., Lee, A. G., Bermak, J. C., Belluzzi, J., Weaver, D. R., Leslie, F. M., & Zhou, Q.-Y. (2002) · Nature · doi:10.1038/417405a · Cited by 715
RecQ helicases: caretakers of the genome
Hickson, I. D. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1012 · Cited by 680
Cantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C. R., Sgroi, D. C., Lane, W. S., Haber, D. A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00304-x · Cited by 674
Self-citationSuppression of tumor growth through disruption of hypoxia-inducible transcription
Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G., & Livingston, D. M. (2000) · Nature Medicine · doi:10.1038/82146 · Cited by 502
Self-citationHomologous recombinational repair of DNA ensures mammalian chromosome stability
Thompson, L. H., & Schild, D. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00115-4 · Cited by 435
The Bloom's Syndrome Gene Product Is a 3′-5′ DNA Helicase
Karow, J., Chakraverty, R. K., & Hickson, I. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30611 · Cited by 383
Flagged first, then by citations
Research works printed but not linked: 2
- Snouwaert, J. N., Pace, A. J., Gowen, L. C., Xiao, A., Nichols, M. A., Xiong, Y. & Koller, B. H. (1999) FASEB J. 13, A1538–A1538.
- Callahan, R. (1998) Biochem. Soc. Symp. 63, 211–221.9513725
Cited by
Sorted by citations
Items 201–240 of 240
Milano, L., Alenezi, W. M., Fierheller, C. T., Serruya, C., Revil, T., Oros, K. K., Bruce, J. J., Spiegelman, D., Pugh, T. J., Mes‐Masson, A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021037 · Cited by 3
Pandey, S. K., Paliwal, S., & Mall, B. B. (2026) · Current Cancer Therapy Reviews · doi:10.2174/0115733947394022250929081154 · Cited by 1
Regulation of BACH1/FANCJ Function in DNA Damage Repair: A Dissertation
Xie, J. (2009) · eScholarship@UMassChan · doi:10.13028/95cm-wn54 · Cited by 1
Somatic Alterations and Implications in Breast Cancer
Ton, C. C. T., Guenthoer, J., & Porter, P. L. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0477-5_9 · Cited by 1
Cortesi, L., Nicolo, A. D., Medici, V., Marino, M., Turchetti, D., Pradella, L. M., Rossi, G., Parisini, E., & Federico, M. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2052-2 · Cited by 1
Ma, B., Wu, J., & Ma, B. (2019) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.1080/13102818.2019.1657039 · Cited by 1
Purification and biochemical characterization of the G4 resolvase and DNA helicase FANCJ
Kulikowicz, T., Sommers, J. A., Fuchs, K. F., Wu, Y., & Brosh, R. M. (2024) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2023.12.006 · Cited by 1
Genetic Predisposition to Male and Female Breast Cancer
Syrjäkoski, K. (2004) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Regulation of DNA damage response by trimeric G-protein SignalingPreprint
El‐Hafeez, A. A. A., Sun, N. N., Chakraborty, A., Ear, J., Roy, S., Chamarthi, P., Rajapakse, N., Das, S., Luker, K. E., Hazra, T. K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.21.452842 · Cited by 1
Kevin, M. J. (2011) · InTech eBooks · doi:10.5772/19486
Characterization of the BACH1 Helicase in the DNA Damage Response Pathway: a Dissertation
Flynn, R. L. (2007) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/ad72-xg56
Morgese, F. (2009) · OpenstarTs (Univeristy of Trieste https://www.units.it/)
DNA helicases in recombination
Klein, H. L. (2007) · Springer eBooks · doi:10.1007/978-3-540-71021-9_5
DNA Helicases: Chemistry and Mechanisms
Pugh, R. A., & Spies, M. (2008) · Wiley Encyclopedia of Chemical Biology · doi:10.1002/9780470048672.wecb133
SURVEY AND SUMMARY DNA helicase and helicase–nuclease enzymes with a conserved iron–sulfur cluster
Wu, Y., & Brosh, R. M. (2011)
Report PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Zhang, F., Ma, J., Wu, J., Ye, L., Cai, H., Xia, B., & Yu, X. (2009)
Self-citationThe Ras effector NORE1A forms a tumor suppressor complex with BRCA1.
Nelson, N. C. (2015) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2336
DNA repair inhibition in anti-cancer therapeutics
Alexander, B. M., & D’Andrea, A. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.091
Nitric oxide cytotoxicity and functions of iron-sulfur enzymes in Escherichia coli
Ren, B. (2009) · Louisiana State University · doi:10.31390/gradschool_dissertations.3786
Genes Involved in the Cisplatin Response of BRCA2 Cancers
Rose, J. M. (2012) · Digital WPI
(2013) · CRC Press eBooks · doi:10.1201/b14587-15
Interrelationship of the Fanconi Anemia/BRCA Pathway
McChesney, P. A., & Kupfer, G. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-69147-3_5
Regulation and Function of the Fanconi Anemia Pathway for Genome Maintenance
Collins, N. B. (2008) · doi:10.18130/v3bp22
Genetic susceptibility to bladder cancer in a cohort of 51 Lebanese patientsPreprint
Kourié, H. R., Haddad, L. E., Chouery, É., Mehawej, C., Jalkh, N., Kassis, M., Zouein, J., Eid, R., Haddad, F. G., Daou, B., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1669372/v1
Data from Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer
Moyer, C. L., Ivanovich, J. L., Gillespie, J. L., Doberstein, R., Radke, M. R., Richardson, M. E., Kaufmann, S. H., Swisher, E. M., & Goodfellow, P. J. (2023) · doi:10.1158/0008-5472.c.6511902.v1
Nicolo, A. D., Tancredi, M., Lombardi, G., Flemma, C. C., Barbuti, S., Cristofano, C. D., Sobhian, B., Bevilacqua, G., Drapkin, R., & Caligo, M. A. (2023) · doi:10.1158/1078-0432.c.6517014
Self-citationNicolo, A. D., Tancredi, M., Lombardi, G., Flemma, C. C., Barbuti, S., Cristofano, C. D., Sobhian, B., Bevilacqua, G., Drapkin, R., & Caligo, M. A. (2023) · doi:10.1158/1078-0432.c.6517014.v1
Self-citationData from Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer
Moyer, C. L., Ivanovich, J. L., Gillespie, J. L., Doberstein, R., Radke, M. R., Richardson, M. E., Kaufmann, S. H., Swisher, E. M., & Goodfellow, P. J. (2023) · doi:10.1158/0008-5472.c.6511902
Calvo, J. A., Fritchman, B., Hernandez, D., Persky, N. S., Johannessen, C. M., Piccioni, F., Kelch, B. A., & Cantor, S. B. (2023) · doi:10.1158/1541-7786.c.6545031.v1
Self-citationSingle-stranded DNA binding protein hitches a ride with the Escherichia coli YoaA-χ helicasePreprint
Weeks-Pollenz, S. J., Petrides, M. J., Davis, R., Harris, K. K., & Bloom, L. B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.21.600097
Lemma, R. B., Fleischer, T., Martinsen, E., Ledsaak, M., Kristensen, V., Eskeland, R., Gabrielsen, O. S., & Mathelier, A. (2022) · Figshare · doi:10.6084/m9.figshare.19619310
Karbassi, S., Nikolova, T., Pfeiffer, D., Nakkeeran, S., Anand, R., Frappart, P., Kuhlen, M., & Hofmann, T. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.24.714005
Structural and biochemical characterization of a novel DinG containing an endonuclease domain
Li, S., Gao, T., Hao, W., Chen, H., Hu, X., Qi, R., Chen, C., & Cheng, K. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06346-3
Mahboob, A., Ahmad, H., Fatma, N., Begum, N., & Husain, A. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01627-w
Loss of the human BRIP1 C terminus does not cause Fanconi anemia
Droste, A., Sobeck, A., Knaup, J., Popp, I., Vodopiutz, J., Janecke, A., Fiebig, B. S., Maringa, M., Faust, U., Carter, N., et al. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.09.009
Guillemette, S. (2014) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2w59b
Metadata
- Authors
- Cantor, S., Drapkin, R., Zhang, F., Lin, Y., Han, J., Pamidi, S., & Livingston, D. M.
- Affiliations
- Harvard University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-02-17
- Volume
- 101
- Issue
- 8
- Pages
- 2357-2362
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC356955
- OpenAlex
- W2122003098
- Cited by
- 240
- References
- 44
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 4 · 2023: 9 · 2022: 7 · 2021: 11 · 2020: 9 · 2019: 6 · 2018: 5 · 2017: 6 · 2016: 6 · 2015: 10 · 2014: 12 · 2013: 14 · 2012: 13
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Update notices
- correction (2004-04-27)
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BACH1, BRCA1, DNA helicase, DNA-dependent ATPase, germline mutations, early-onset breast cancer, ovarian cancer, DNA double-strand break repair, DNA repair, protein-protein interaction, hereditary cancer predisposition
- MeSH terms
- Adenosine Triphosphatases, DNA Helicases, Humans, Nuclear Proteins, Transcription Factors, Mutagenesis, Site-Directed, Leucine Zippers, Germ-Line Mutation, BRCA1 Protein, Amino Acid Substitution, Basic-Leucine Zipper Transcription Factors, Fanconi Anemia Complementation Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
